Showing results (181-190 of 752) with videos related to
Sort By:
Pageof 76
Discovery Medicine|July 16, 2015
One size should not fit all: advancing toward personalized glioblastoma therapyDavid A Reardon, Keith L Ligon, E Antonio Chiocca, et al.Current Neurology and Neuroscience Reports|May 24, 2020
Novel Therapies for GlioblastomaElisa K Liu, Erik P Sulman, Patrick Y Wen, et al.Journal of Neuro-Oncology|September 8, 2010
Medical therapies for meningiomasPatrick Y Wen, Eudocia Quant, Jan Drappatz, et al.Expert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.Current Oncology Reports|February 9, 2006
Targeted molecular therapy of malignant gliomasSantosh Kesari, Naren Ramakrishna, Claire Sauvageot, et al.Journal of Neuro-Oncology|September 27, 2007
Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphomaAlfredo D Voloschin, Rebecca Betensky, Patrick Y Wen, et al.JAMA Oncology|August 25, 2022
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A ReviewTamar R Berger, Patrick Y Wen, Melanie Lang-Orsini, et al.Frontiers in Neurology|March 11, 2015
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining responseRaymond Y Huang, Martha R Neagu, David A Reardon, et al.Neuro-Oncology|May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumabJeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.Neuro-Oncology|August 24, 2018
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working GroupRaymond Y Huang, Wenya Linda Bi, Michael Weller, et al.Pageof 76